Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AdaptHealth Corp.AHCO · Entity 5183 | Director | August 06, 2026 | August 14, 2026 |
| MOLINA HEALTHCARE, INC.MOH · Entity 3504 | Director | October 01, 2026 | October 03, 2026 |
| eHealth, Inc.EHTH · Entity 497 | Director | June 18, 2026 | June 23, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AdaptHealth Corp.
Report date August 06, 2026 · Filed August 14, 2026 · Amendment
Amendment: balances below belong to this corrected disclosure, not necessarily a complete replacement of earlier positions.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 143,234 |
Reported balance
After 2026-08-06 transaction · row 1
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 1 · 2026-08-06 · Purchase · Acquired 20,000 · Balance 143,234 F1: The Form 4 originally filed on August 10, 2026 is being amended to report the correct pricing of the shares purchased by the Reporting Person. These shares were purchased in multiple transactions at prices ranging from $6.26 to $6.335, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1). |
| Common StockSEC Table I · non-derivative | IndirectBy Trust | 34,000 |
Reported balance
Holding disclosure · report date 2026-08-06 · row 2
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 2 · Balance 34,000 F2: Securities held by the Dale B. Wolf Generation Skipping Trust (the "GST"). The reporting person is the investment manager of the GST. |
Filing footnotes · ownership attribution and instrument terms
F1: The Form 4 originally filed on August 10, 2026 is being amended to report the correct pricing of the shares purchased by the Reporting Person. These shares were purchased in multiple transactions at prices ranging from $6.26 to $6.335, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1).
F2: Securities held by the Dale B. Wolf Generation Skipping Trust (the "GST"). The reporting person is the investment manager of the GST.
MOLINA HEALTHCARE, INC.
Report date October 01, 2026 · Filed October 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectHeld by Trust | 15,937 |
Reported balance
After 2026-10-01 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2026-10-01 · Grant · Acquired 304 · Balance 15,937 F1: Grant of stock under the Issuer's 2025 Equity Incentive Plan in connection with the Reporting Person's services as a Director. F2: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on October 1, 2026 was $180.85, which resulted in a grant of 304 shares. F3: Represents the closing price of the Issuer's common stock on October 1, 2026. F4: Shares are held by Dale B. Wolf Revocable Trust, of which Dale B. Wolf is the sole trustee. |
Filing footnotes · ownership attribution and instrument terms
F1: Grant of stock under the Issuer's 2025 Equity Incentive Plan in connection with the Reporting Person's services as a Director.
F2: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on October 1, 2026 was $180.85, which resulted in a grant of 304 shares.
F3: Represents the closing price of the Issuer's common stock on October 1, 2026.
F4: Shares are held by Dale B. Wolf Revocable Trust, of which Dale B. Wolf is the sole trustee.
eHealth, Inc.
Report date June 18, 2026 · Filed June 23, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 184,174 |
Reported balance
After 2026-06-18 transaction · row 1
1 source rowRow 1 · 2026-06-18 · Grant · Acquired 61,041 · Balance 184,174 F1: This represents an annual award of restricted stock units ("RSUs") to the Issuer's non-employee directors. Each RSU represents a contingent right to receive one share of the Issuer's common stock upon vesting. The RSUs vest in four equal quarterly installments from the vesting commencement date of June 18, 2026, subject to the individual's continued status as a Service Provider (as defined in the Issuer's Amended and Restated 2024 Equity Incentive Plan (the "Plan")) through the applicable vesting date; provided, however, that any then-unvested RSUs shall vest in full (i) on the day immediately prior to the date of the Issuer's next annual stockholder meeting or (ii) if the Issuer is subject to a Change in Control (as defined in the Plan), subject in each case to the individual's continued status as a Service Provider through such vesting date. |
| Common StockSEC Table I · non-derivative | IndirectBy Trust | 62,932 |
Reported balance
Holding disclosure · report date 2026-06-18 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 62,932 F2: Shares held by the Dale B. Wolf Generation Skipping Trust. |
Filing footnotes · ownership attribution and instrument terms
F1: This represents an annual award of restricted stock units ("RSUs") to the Issuer's non-employee directors. Each RSU represents a contingent right to receive one share of the Issuer's common stock upon vesting. The RSUs vest in four equal quarterly installments from the vesting commencement date of June 18, 2026, subject to the individual's continued status as a Service Provider (as defined in the Issuer's Amended and Restated 2024 Equity Incentive Plan (the "Plan")) through the applicable vesting date; provided, however, that any then-unvested RSUs shall vest in full (i) on the day immediately prior to the date of the Issuer's next annual stockholder meeting or (ii) if the Issuer is subject to a Change in Control (as defined in the Plan), subject in each case to the individual's continued status as a Service Provider through such vesting date.
F2: Shares held by the Dale B. Wolf Generation Skipping Trust.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 01, 2026 Filed Oct 3, 2026 00:53 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GrantCommon Stock | 304 | $180.85 | $54,978.40 |
DisclosureSEC source: 0001228861-26-000010 · wk-form4_1790974396.xml · nonDerivative · entry 1 WOLF DALE B · CIK 0001228861 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by Trust Disclosed balance after: 15,937 F1 · kind: Grant of stock under the Issuer's 2025 Equity Incentive Plan in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on October 1, 2026 was $180.85, which resulted in a grant of 304 shares. F3 · price: Represents the closing price of the Issuer's common stock on October 1, 2026. F4 · ownership.nature: Shares are held by Dale B. Wolf Revocable Trust, of which Dale B. Wolf is the sole trustee. Read SEC document |
| August 07, 2026 Filed Aug 11, 2026 00:02 UTC | AdaptHealth Corp. AHCO · Entity 5183 | PurchaseCommon Stock | 20,000 | $5.86 | $117,200.00 |
DisclosureSEC source: 0001104659-26-093575 · tm2622716-1_4seq1.xml · nonDerivative · entry 2 WOLF DALE B · CIK 0001228861 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 34,000 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.83 to $5.885, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1). F2 · ownership.nature: Securities held by the Dale B. Wolf Generation Skipping Trust (the "GST"). The reporting person is the investment manager of the GST. Read SEC document |
| August 06, 2026 Filed Aug 11, 2026 00:02 UTC | AdaptHealth Corp. AHCO · Entity 5183 | PurchaseCommon Stock | 20,000 | $6.37 | $127,400.00 |
DisclosureSEC source: 0001104659-26-093575 · tm2622716-1_4seq1.xml · nonDerivative · entry 1 WOLF DALE B · CIK 0001228861 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 143,234 Read SEC document |
| August 06, 2026 Filed Aug 14, 2026 20:01 UTC Amendment | AdaptHealth Corp. AHCO · Entity 5183 | PurchaseCommon Stock | 20,000 | $6.30 | $126,000.00 |
DisclosureSEC source: 0001104659-26-097053 · tm2623267-1_4aseq1.xml · nonDerivative · entry 1 WOLF DALE B · CIK 0001228861 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 143,234 F1 · price: The Form 4 originally filed on August 10, 2026 is being amended to report the correct pricing of the shares purchased by the Reporting Person. These shares were purchased in multiple transactions at prices ranging from $6.26 to $6.335, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1). Read SEC document |
| July 01, 2026 Filed Jul 2, 2026 20:53 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GrantCommon Stock | 237 | $232.55 | $55,114.35 |
DisclosureSEC source: 0001228861-26-000008 · wk-form4_1783025589.xml · nonDerivative · entry 1 WOLF DALE B · CIK 0001228861 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by Trust Disclosed balance after: 15,633 F1 · kind: Grant of stock under the Issuer's 2025 Equity Incentive Plan in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on July 1, 2026 was $232.55, which resulted in a grant of 237 shares. F3 · price: Represents the closing price of the Issuer's common stock on July 1, 2026. F4 · ownership.nature: Shares are held by Dale B. Wolf Revocable Trust, of which Dale B. Wolf is the sole trustee. Read SEC document |
| June 24, 2026 Filed Jun 26, 2026 20:04 UTC | AdaptHealth Corp. AHCO · Entity 5183 | GrantCommon Stock | 18,999 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-078240 · tm2619030d3_4seq1.xml · nonDerivative · entry 1 WOLF DALE B · CIK 0001228861 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 123,234 F1 · price: These shares represent restricted stock units and will be settled in common stock upon vesting. Read SEC document |
| June 18, 2026 Filed Jun 23, 2026 20:13 UTC | eHealth, Inc. EHTH · Entity 497 | GrantCommon Stock | 61,041 | $0.00 | $0.00 |
DisclosureSEC source: 0001228861-26-000006 · wk-form4_1782245597.xml · nonDerivative · entry 1 WOLF DALE B · CIK 0001228861 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 184,174 F1 · shares: This represents an annual award of restricted stock units ("RSUs") to the Issuer's non-employee directors. Each RSU represents a contingent right to receive one share of the Issuer's common stock upon vesting. The RSUs vest in four equal quarterly installments from the vesting commencement date of June 18, 2026, subject to the individual's continued status as a Service Provider (as defined in the Issuer's Amended and Restated 2024 Equity Incentive Plan (the "Plan")) through the applicable vesting date; provided, however, that any then-unvested RSUs shall vest in full (i) on the day immediately prior to the date of the Issuer's next annual stockholder meeting or (ii) if the Issuer is subject to a Change in Control (as defined in the Plan), subject in each case to the individual's continued status as a Service Provider through such vesting date. Read SEC document |
| April 01, 2026 Filed Apr 2, 2026 20:46 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GrantCommon Stock | 405 | $135.82 | $55,007.10 |
DisclosureSEC source: 0001228861-26-000004 · wk-form4_1775162812.xml · nonDerivative · entry 1 WOLF DALE B · CIK 0001228861 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by Trust Disclosed balance after: 15,396 F1 · kind: Grant of stock under the Issuer's 2025 Equity Incentive Plan in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on April 1, 2026 was $135.82, which resulted in a grant of 405 shares. F3 · price: Represents the closing price of the Issuer's common stock on April 1, 2026. F4 · ownership.nature: Shares are held by Dale B. Wolf Revocable Trust, of which Dale B. Wolf is the sole trustee. Read SEC document |
| February 27, 2026 Filed Mar 3, 2026 23:41 UTC | AdaptHealth Corp. AHCO · Entity 5183 | PurchaseCommon Stock | 8,000 | $8.96 | $71,680.00 |
DisclosureSEC source: 0001104659-26-023001 · tm267918-1_4seq1.xml · nonDerivative · entry 1 WOLF DALE B · CIK 0001228861 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 104,235 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.94 to $8.99, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1) . Read SEC document |
| January 01, 2026 Filed Jan 2, 2026 21:51 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GrantCommon Stock | 317 | $173.54 | $55,012.18 |
DisclosureSEC source: 0001228861-26-000002 · wk-form4_1767390671.xml · nonDerivative · entry 1 WOLF DALE B · CIK 0001228861 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by Trust Disclosed balance after: 14,991 F1 · kind: Grant of stock under the Issuer's 2025 Equity Incentive Plan in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. Since the grant date of January 1, 2026, was a non-trading day, the number of shares was calculated based on the closing price of the Issuer's common stock on December 31, 2025, of $173.54. Thus, the grant this quarter for services as a Director is for 317 shares of the Issuer's common stock. F3 · price: Represents the closing price of the Issuer's common stock on December 31, 2025. F4 · ownership.nature: Shares are held by Dale B. Wolf Revocable Trust, of which Dale B. Wolf is the sole trustee. Read SEC document |
| October 01, 2025 Filed Oct 3, 2025 00:08 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GrantCommon Stock | 285 | $192.79 | $54,945.15 |
DisclosureSEC source: 0001228861-25-000005 · wk-form4_1759450080.xml · nonDerivative · entry 1 WOLF DALE B · CIK 0001228861 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by Trust Disclosed balance after: 14,674 F1 · kind: Grant of stock under the Issuer's 2025 Equity Incentive Plan in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on October 1, 2025 was $192.79, which resulted in a grant of 285 shares. F3 · price: Represents the closing price of the Issuer's common stock on October 1, 2025. F4 · ownership.nature: Shares are held by Dale B. Wolf Revocable Trust, of which Dale B. Wolf is the sole trustee. Read SEC document |
| July 01, 2025 Filed Jul 2, 2025 21:21 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GrantCommon Stock | 180 | $306.29 | $55,132.20 |
DisclosureSEC source: 0001179929-25-000111 · wk-form4_1751491273.xml · nonDerivative · entry 1 WOLF DALE B · CIK 0001228861 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by Trust Disclosed balance after: 14,389 F1 · kind: Grant of stock under the Issuer's 2025 Equity Incentive Plan in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on July 1, 2025 was $306.29, which resulted in a grant of 180 shares. F3 · price: Represents the closing price of the Issuer's common stock on July 1, 2025. F4 · ownership.nature: Shares are held by Dale B. Wolf Revocable Trust, of which Dale B. Wolf is the sole trustee. Read SEC document |
| June 26, 2025 Filed Jun 30, 2025 23:33 UTC | AdaptHealth Corp. AHCO · Entity 5183 | GrantCommon Stock | 21,346 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-064282 · tm2519424-4_4seq1.xml · nonDerivative · entry 1 WOLF DALE B · CIK 0001228861 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 96,235 Read SEC document |
| June 17, 2025 Filed Jun 20, 2025 20:12 UTC | eHealth, Inc. EHTH · Entity 497 | GrantCommon Stock | 34,574 | $0.00 | $0.00 |
DisclosureSEC source: 0001333493-25-000072 · wk-form4_1750450324.xml · nonDerivative · entry 1 WOLF DALE B · CIK 0001228861 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 123,133 F1 · shares: This represents an annual award of restricted stock units ("RSUs") to the Issuer's non-employee directors. Each RSU represents a contingent right to receive one share of the Issuer's common stock upon vesting. The RSUs vest in four equal quarterly installments from the vesting commencement date of June 17, 2025, subject to the individual's continued status as a Service Provider (as defined in the Issuer's 2024 Equity Incentive Plan (the "Plan")) through the applicable vesting date; provided, however, that any then-unvested RSUs shall vest in full (i) on the day immediately prior to the date of the Issuer's next annual stockholder meeting or (ii) if the Issuer is subject to a Change in Control (as defined in the Plan), subject in each case to the individual's continued status as a Service Provider through such vesting date. Read SEC document |
| May 21, 2025 Filed May 22, 2025 20:39 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | SaleCommon Stock | 100 | $324.42 | $32,442.00 |
DisclosureSEC source: 0001179929-25-000091 · wk-form4_1747946343.xml · nonDerivative · entry 4 WOLF DALE B · CIK 0001228861 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by Trust Disclosed balance after: 14,209 F5 · price: Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $324.42 to $324.45. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price. F2 · ownership.nature: Shares are held by Dale B. Wolf Revocable Trust, of which Dale B. Wolf is the sole trustee. Reflects a transfer of 15,709 shares of common stock to Dale B. Wolf Revocable Trust that was exempt from reporting. Read SEC document |
| May 21, 2025 Filed May 22, 2025 20:39 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | SaleCommon Stock | 900 | $323.27 | $290,943.00 |
DisclosureSEC source: 0001179929-25-000091 · wk-form4_1747946343.xml · nonDerivative · entry 3 WOLF DALE B · CIK 0001228861 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by Trust Disclosed balance after: 14,309 F4 · price: Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $322.93 to $323.68. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price. F2 · ownership.nature: Shares are held by Dale B. Wolf Revocable Trust, of which Dale B. Wolf is the sole trustee. Reflects a transfer of 15,709 shares of common stock to Dale B. Wolf Revocable Trust that was exempt from reporting. Read SEC document |
| May 21, 2025 Filed May 22, 2025 20:39 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | SaleCommon Stock | 400 | $322.23 | $128,892.00 |
DisclosureSEC source: 0001179929-25-000091 · wk-form4_1747946343.xml · nonDerivative · entry 2 WOLF DALE B · CIK 0001228861 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by Trust Disclosed balance after: 15,209 F3 · price: Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $321.90 to $322.62. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price. F2 · ownership.nature: Shares are held by Dale B. Wolf Revocable Trust, of which Dale B. Wolf is the sole trustee. Reflects a transfer of 15,709 shares of common stock to Dale B. Wolf Revocable Trust that was exempt from reporting. Read SEC document |
| May 21, 2025 Filed May 22, 2025 20:39 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | SaleCommon Stock | 100 | $320.51 | $32,051.00 |
DisclosureSEC source: 0001179929-25-000091 · wk-form4_1747946343.xml · nonDerivative · entry 1 WOLF DALE B · CIK 0001228861 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by Trust Disclosed balance after: 15,609 F1 · price: Represents the selling price per share of all 100 shares. F2 · ownership.nature: Shares are held by Dale B. Wolf Revocable Trust, of which Dale B. Wolf is the sole trustee. Reflects a transfer of 15,709 shares of common stock to Dale B. Wolf Revocable Trust that was exempt from reporting. Read SEC document |
| April 01, 2025 Filed Apr 2, 2025 21:00 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GrantCommon Stock | 168 | $327.71 | $55,055.28 |
DisclosureSEC source: 0001179929-25-000063 · wk-form4_1743627646.xml · nonDerivative · entry 1 WOLF DALE B · CIK 0001228861 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,709 F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on April 1, 2025 was $327.71, which resulted in a grant of 168 shares. F3 · price: Represents the closing price of the Issuer's common stock on April 1, 2025. Read SEC document |
| January 01, 2025 Filed Jan 2, 2025 22:20 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GrantCommon Stock | 189 | $291.05 | $55,008.45 |
DisclosureSEC source: 0001179929-25-000016 · wk-form4_1735856439.xml · nonDerivative · entry 1 WOLF DALE B · CIK 0001228861 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,541 F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. Since the grant date of January 1, 2025, was a non-trading day, the number of shares was calculated based on the closing price of the Issuer's common stock on December 31, 2024, of $291.05. Thus, the grant this quarter for services as a Director is for 189 shares of the Issuer's common stock. F3 · price: Represents the closing price of the Issuer's common stock on December 31, 2024. Read SEC document |
| November 13, 2024 Filed Nov 15, 2024 21:15 UTC | AdaptHealth Corp. AHCO · Entity 5183 | SaleCommon Stock | 7,000 | $10.80 | $75,600.00 |
DisclosureSEC source: 0001104659-24-119719 · tm2428564d1_4seq1.xml · nonDerivative · entry 1 WOLF DALE B · CIK 0001228861 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 74,889 Read SEC document |
| November 11, 2024 Filed Nov 13, 2024 21:20 UTC | eHealth, Inc. EHTH · Entity 497 | SaleCommon Stock | 16,403 | $5.22 | $85,664.67 |
DisclosureSEC source: 0001333493-24-000177 · wk-form4_1731532835.xml · nonDerivative · entry 2 WOLF DALE B · CIK 0001228861 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 88,559 F1 · price: The price reported in Table I, Column 4 for sales on 11/11/2024 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.20 to $5.35, inclusive. The reporting person undertakes to provide to eHealth, Inc., any security holder of eHealth, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 08, 2024 Filed Nov 13, 2024 21:20 UTC | eHealth, Inc. EHTH · Entity 497 | SaleCommon Stock | 3,597 | $5.35 | $19,243.95 |
DisclosureSEC source: 0001333493-24-000177 · wk-form4_1731532835.xml · nonDerivative · entry 1 WOLF DALE B · CIK 0001228861 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 104,962 Read SEC document |
| October 01, 2024 Filed Oct 2, 2024 20:44 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GrantCommon Stock | 161 | $341.91 | $55,047.51 |
DisclosureSEC source: 0001179929-24-000142 · wk-form4_1727901836.xml · nonDerivative · entry 1 WOLF DALE B · CIK 0001228861 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,352 F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on October 1, 2024, was $341.91, which resulted in a grant of 161 shares. F3 · price: Represents the closing price of the Issuer's common stock on October 1, 2024. Read SEC document |
| July 01, 2024 Filed Jul 2, 2024 20:58 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GrantCommon Stock | 188 | $292.16 | $54,926.08 |
DisclosureSEC source: 0001179929-24-000114 · wk-form4_1719953916.xml · nonDerivative · entry 1 WOLF DALE B · CIK 0001228861 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,191 F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on July 1, 2024, was $292.16, which resulted in a grant of 188 shares. F3 · price: Represents the closing price of the Issuer's common stock on July 1, 2024. Read SEC document |
| June 24, 2024 Filed Jun 26, 2024 22:57 UTC | AdaptHealth Corp. AHCO · Entity 5183 | GrantCommon Stock | 25,101 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-075259 · tm2418291-6_4seq1.xml · nonDerivative · entry 1 WOLF DALE B · CIK 0001228861 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 81,889 Read SEC document |
| June 11, 2024 Filed Jun 13, 2024 20:52 UTC | eHealth, Inc. EHTH · Entity 497 | GrantCommon Stock | 31,760 | $0.00 | $0.00 |
DisclosureSEC source: 0001333493-24-000104 · wk-form4_1718311913.xml · nonDerivative · entry 1 WOLF DALE B · CIK 0001228861 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 108,559 F1 · shares: This represents an annual award of restricted stock units ("RSUs") to the Issuer's non-employee directors. Each RSU represents a contingent right to receive one share of the Issuer's common stock upon vesting. The RSUs vest in four equal quarterly installments from the vesting commencement date of June 11, 2024, subject to the individual continuing to provide Service (as defined in the Issuer's Amended and Restated 2014 Equity Incentive Plan (the "Plan")) through the applicable vesting date; provided, however, that any then-unvested RSUs shall vest in full (i) on the day immediately prior to the date of the Issuer's next annual stockholder meeting or (ii) if the Issuer is subject to a Change in Control (as defined in the Plan), subject in each case to the individual's continued Service through such vesting date. Read SEC document |
| April 01, 2024 Filed Apr 2, 2024 20:57 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GrantCommon Stock | 136 | $404.20 | $54,971.20 |
DisclosureSEC source: 0001179929-24-000080 · wk-form4_1712091409.xml · nonDerivative · entry 1 WOLF DALE B · CIK 0001228861 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,003 F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on April 1, 2024, was $404.20, which resulted in a grant of 136 shares. F3 · price: Represents the closing price of the Issuer's common stock on April 1, 2024. Read SEC document |
| February 15, 2024 Filed Feb 16, 2024 21:46 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | SaleCommon Stock | 1,500 | $398.38 | $597,570.00 |
DisclosureSEC source: 0001179929-24-000042 · wk-form4_1708120005.xml · nonDerivative · entry 1 WOLF DALE B · CIK 0001228861 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,867 F1 · price: Represents the selling price per share of all 1,500 shares. Read SEC document |
| January 01, 2024 Filed Jan 3, 2024 00:24 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GrantCommon Stock | 152 | $361.31 | $54,919.12 |
DisclosureSEC source: 0001179929-24-000023 · wk-form4_1704241446.xml · nonDerivative · entry 1 WOLF DALE B · CIK 0001228861 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,367 F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. Since the grant date of January 1, 2024, was a non-trading day, the number of shares was calculated based on the closing price of the Issuer's common stock on December 29, 2023, of $361.31. Thus, the grant this quarter for services as a Director is for 152 shares of the Issuer's common stock. F3 · price: Represents the closing price of the Issuer's common stock on December 29, 2023. Read SEC document |
| October 01, 2023 Filed Oct 2, 2023 23:31 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GrantCommon Stock | 168 | $327.89 | $55,085.52 |
DisclosureSEC source: 0001179929-23-000125 · wk-form4_1696289499.xml · nonDerivative · entry 1 WOLF DALE B · CIK 0001228861 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,215 F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. Since the grant date of October 1, 2023, was a non-trading day, the number of shares was calculated based on the closing price of the Issuer's common stock on September 29, 2023, of $327.89. Thus, the grant this quarter for services as a Director is for 168 shares of the Issuer's common stock. F3 · price: Represents the closing price of the Issuer's common stock on September 29, 2023. Read SEC document |
| September 15, 2023 Filed Sep 19, 2023 20:05 UTC | eHealth, Inc. EHTH · Entity 497 | PurchaseCommon Stock | 15,000 | $7.05 | $105,705.00 |
DisclosureSEC source: 0001333493-23-000121 · wk-form4_1695153933.xml · nonDerivative · entry 1 WOLF DALE B · CIK 0001228861 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 62,932 F1 · price: The price reported in Table I, Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.92 to $7.10, inclusive. The reporting person undertakes to provide to eHealth, Inc., any security holder of eHealth, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price with the range set forth in this footnote. F2 · ownership.nature: Shares held by the Dale B. Wolf Generation Skipping Trust. Read SEC document |
| July 01, 2023 Filed Jul 3, 2023 20:56 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GrantCommon Stock | 183 | $301.24 | $55,126.92 |
DisclosureSEC source: 0001179929-23-000085 · wk-form4_1688417754.xml · nonDerivative · entry 1 WOLF DALE B · CIK 0001228861 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,047 F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. Since the grant date of July 1, 2023, was a non-trading day, the number of shares was calculated based on the closing price of the Issuer's common stock on June 30, 2023, of $301.24. Thus, the grant this quarter for services as a Director is for 183 shares of the Issuer's common stock. F3 · price: Represents the closing price of the Issuer's common stock on June 30, 2023. Read SEC document |
| June 22, 2023 Filed Jun 27, 2023 01:02 UTC | AdaptHealth Corp. AHCO · Entity 5183 | GrantCommon Stock | 15,949 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-074900 · tm2319712-3_4seq1.xml · nonDerivative · entry 1 WOLF DALE B · CIK 0001228861 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56,788 Read SEC document |
| June 14, 2023 Filed Jun 16, 2023 21:50 UTC | eHealth, Inc. EHTH · Entity 497 | GrantCommon Stock | 24,446 | $0.00 | $0.00 |
DisclosureSEC source: 0001333493-23-000091 · wk-form4_1686952233.xml · nonDerivative · entry 1 WOLF DALE B · CIK 0001228861 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 76,799 F1 · shares: This represents an annual award of restricted stock units to the Company's non-employee directors. Each unit represents a contingent right to receive one share of the Company's common stock upon vesting. The restricted stock units vest in four equal quarterly installments from the vesting commencement date of June 14, 2023, subject to the individual continuing to provide services to the Company through the applicable vesting date; provided, however, that any then-unvested shares shall vest, subject to the individual's continued service through such vesting date, in full on the day immediately prior to the date of the Company's next annual stockholder meeting. The restricted stock units will also become 100% vested if the Company is subject to a change in control before the individual's service terminates. Read SEC document |
| May 31, 2023 Filed Jun 1, 2023 21:12 UTC | eHealth, Inc. EHTH · Entity 497 | PurchaseCommon Stock | 2,668 | $6.42 | $17,132.03 |
DisclosureSEC source: 0001333493-23-000069 · wk-form4_1685653918.xml · nonDerivative · entry 2 WOLF DALE B · CIK 0001228861 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 47,932 F3 · price: The price reported in Table I, Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.39 to $6.45, inclusive. F2 · ownership.nature: Shares held by the Dale B. Wolf Generation Skipping Trust. Read SEC document |
| May 30, 2023 Filed Jun 1, 2023 21:12 UTC | eHealth, Inc. EHTH · Entity 497 | PurchaseCommon Stock | 10,264 | $6.37 | $65,417.60 |
DisclosureSEC source: 0001333493-23-000069 · wk-form4_1685653918.xml · nonDerivative · entry 1 WOLF DALE B · CIK 0001228861 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 45,264 F1 · price: The price reported in Table I, Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.35 to $6.40, inclusive. The reporting person undertakes to provide to eHealth, Inc., any security holder of eHealth, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price with the ranges set forth in footnotes (1) and (3) of this Form 4. F2 · ownership.nature: Shares held by the Dale B. Wolf Generation Skipping Trust. Read SEC document |
| April 01, 2023 Filed Apr 3, 2023 22:50 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GrantCommon Stock | 206 | $267.49 | $55,102.94 |
DisclosureSEC source: 0001179929-23-000060 · wf-form4_168056219613150.xml · nonDerivative · entry 1 WOLF DALE B · CIK 0001228861 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,864 F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each Director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. Since the grant date of April 1, 2023, was a non-trading day, the number of shares was calculated based on the closing price of the Issuer's common stock on March 31, 2023, of $267.49. Thus, the grant this quarter for services as a Director is for 206 shares of the Issuer's common stock. F3 · price: Represents the closing price of the Issuer's common stock on March 31, 2023. Read SEC document |
| January 01, 2023 Filed Jan 3, 2023 23:23 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GrantCommon Stock | 167 | $330.22 | $55,146.74 |
DisclosureSEC source: 0001179929-23-000015 · wf-form4_167278817270601.xml · nonDerivative · entry 1 WOLF DALE B · CIK 0001228861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,658 F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. Since the grant date of January 1, 2023, was a non-trading day, the number of shares was calculated based on the closing price of the Issuer's common stock on December 30, 2022, of $330.22. Thus, the grant this quarter for services as a Director is for 167 shares of the Issuer's common stock. F3 · price: Represents the closing price of the Issuer's common stock on December 30, 2022. Read SEC document |
| December 07, 2022 Filed Dec 9, 2022 00:59 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | SaleCommon Stock | 50 | $341.30 | $17,065.00 |
DisclosureSEC source: 0001179929-22-000184 · wf-form4_167054751889276.xml · nonDerivative · entry 4 WOLF DALE B · CIK 0001228861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,491 F4 · price: Represents the actual selling price per share of all 50 shares. Read SEC document |
| December 07, 2022 Filed Dec 9, 2022 00:59 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | SaleCommon Stock | 347 | $340.75 | $118,240.25 |
DisclosureSEC source: 0001179929-22-000184 · wf-form4_167054751889276.xml · nonDerivative · entry 3 WOLF DALE B · CIK 0001228861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,541 F3 · price: Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $340.25 to $341.23. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price. Read SEC document |
| December 07, 2022 Filed Dec 9, 2022 00:59 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | SaleCommon Stock | 1,253 | $339.54 | $425,443.62 |
DisclosureSEC source: 0001179929-22-000184 · wf-form4_167054751889276.xml · nonDerivative · entry 2 WOLF DALE B · CIK 0001228861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,888 F2 · price: Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $339.22 to $340.20. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price. Read SEC document |
| December 07, 2022 Filed Dec 9, 2022 00:59 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | SaleCommon Stock | 850 | $338.83 | $288,005.50 |
DisclosureSEC source: 0001179929-22-000184 · wf-form4_167054751889276.xml · nonDerivative · entry 1 WOLF DALE B · CIK 0001228861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,141 F1 · price: Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $338.22 to $339.20. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price. Read SEC document |
| November 17, 2022 Filed Nov 21, 2022 21:09 UTC | eHealth, Inc. EHTH · Entity 497 | SaleCommon Stock | 5,000 | $3.24 | $16,221.50 |
DisclosureSEC source: 0001333493-22-000150 · wf-form4_166906496206072.xml · nonDerivative · entry 1 WOLF DALE B · CIK 0001228861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,353 F1 · price: The price reported in Table I, Column 4 for sales on 11/17/2022 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.23 to $3.265, inclusive. The reporting person undertakes to provide to eHealth, Inc., any security holder of eHealth, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price with the range set forth in this footnote. Read SEC document |
| November 07, 2022 Filed Nov 8, 2022 02:05 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | Exercise / conversionStock Option (Right to Buy) · Derivative | 6,000 | $33.02 Strike: $33.02 | $198,120.00 |
DisclosureSEC source: 0001179929-22-000178 · wf-form4_166787312345320.xml · derivative · entry 2 WOLF DALE B · CIK 0001228861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,000 shares Expires 2023-03-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The options are fully vested. Read SEC document |
| November 07, 2022 Filed Nov 8, 2022 02:05 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | Exercise / conversionCommon Stock | 6,000 | $33.02 | $198,120.00 |
DisclosureSEC source: 0001179929-22-000178 · wf-form4_166787312345320.xml · nonDerivative · entry 1 WOLF DALE B · CIK 0001228861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,991 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 01, 2022 Filed Oct 5, 2022 17:47 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | GrantCommon Stock | 167 | $329.84 | $55,083.28 |
DisclosureSEC source: 0001179929-22-000163 · wf-form4_166499204280853.xml · nonDerivative · entry 1 WOLF DALE B · CIK 0001228861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,991 F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director. F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. Since the grant date of October 1, 2022 was a non-trading day, the number of shares was calculated based on the closing price of the Issuer's common stock on September 30, 2022, of $329.84. Thus, the grant this quarter for services as a Director is for 167 shares of the Issuer's common stock. F3 · price: Represents the closing price of the Issuer's common stock on September 30, 2022. Read SEC document |
| August 02, 2022 Filed Aug 4, 2022 00:17 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,000 | $33.02 Strike: $33.02 | $66,040.00 |
DisclosureSEC source: 0001179929-22-000116 · wf-form4_165957223285721.xml · derivative · entry 3 WOLF DALE B · CIK 0001228861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 Underlying: Common Stock · 2,000 shares Expires 2023-03-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The options are fully vested. Read SEC document |
| August 02, 2022 Filed Aug 4, 2022 00:17 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | SaleCommon Stock | 2,000 | $327.99 | $655,980.00 |
DisclosureSEC source: 0001179929-22-000116 · wf-form4_165957223285721.xml · nonDerivative · entry 2 WOLF DALE B · CIK 0001228861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,824 F1 · price: Represents the selling price per share of all 2,000 shares. Read SEC document |
| August 02, 2022 Filed Aug 4, 2022 00:17 UTC | MOLINA HEALTHCARE, INC. MOH · Entity 3504 | Exercise / conversionCommon Stock | 2,000 | $33.02 | $66,040.00 |
DisclosureSEC source: 0001179929-22-000116 · wf-form4_165957223285721.xml · nonDerivative · entry 1 WOLF DALE B · CIK 0001228861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,824 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.